Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pär Stattin"'
Publikováno v:
Journal of Urology. 204:714-719
5α-Reductase inhibitors reduced the risk of prostate cancer in 25% in 2 randomized trials but increased the risk of Gleason 8-10 at biopsy. One explanation is that 5α-reductase inhibitors induce morphological changes in prostate cancer cells simila
Autor:
Stacy Loeb, Anna Bill-Axelson, Linda Drevin, Pär Stattin, Karl-Johan Lundström, Stefan Carlsson, Hans Garmo
Publikováno v:
Journal of Urology. 192:1116-1122
Transrectal ultrasound guided biopsy is the gold standard for detecting prostate cancer but international reports suggest that increasing risks are associated with the procedure. We estimated incidence and risk factors for infection after prostate bi
Publikováno v:
Journal of Urology. 180:2423-2430
To what extent active surveillance and deferred treatment for localized risk prostate cancer are used is unclear. We assessed the use of surveillance and of deferred treatment in a population based, nationwide cohort in Sweden.In the National Prostat
Publikováno v:
Journal of Urology. 195:1172-1173
Re : Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma